| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |